96 related articles for article (PubMed ID: 17507220)
1. Synthesis and preliminary evaluation of mono-[123I]iodohypericin monocarboxylic acid as a necrosis avid imaging agent.
Fonge H; Jin L; Wang H; Ni Y; Bormans G; Verbruggen A
Bioorg Med Chem Lett; 2007 Jul; 17(14):4001-5. PubMed ID: 17507220
[TBL] [Abstract][Full Text] [Related]
2. First preclinical evaluation of mono-[123I]iodohypericin as a necrosis-avid tracer agent.
Ni Y; Huyghe D; Verbeke K; de Witte PA; Nuyts J; Mortelmans L; Chen F; Marchal G; Verbruggen AM; Bormans GM
Eur J Nucl Med Mol Imaging; 2006 May; 33(5):595-601. PubMed ID: 16450141
[TBL] [Abstract][Full Text] [Related]
3. Radiolabeled iodohypericin as tumor necrosis avid tracer: diagnostic and therapeutic potential.
Van de Putte M; Marysael T; Fonge H; Roskams T; Cona MM; Li J; Bormans G; Verbruggen A; Ni Y; de Witte PA
Int J Cancer; 2012 Jul; 131(2):E129-37. PubMed ID: 22038886
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and Preclinical Evaluation of Radioiodinated Hypericin Dicarboxylic Acid as a Necrosis Avid Agent in Rat Models of Induced Hepatic, Muscular, and Myocardial Necroses.
Li J; Zhang J; Yang S; Jiang C; Zhang D; Jin Q; Wang Q; Wang C; Ni Y; Yin Z; Song S
Mol Pharm; 2016 Jan; 13(1):232-40. PubMed ID: 26568406
[TBL] [Abstract][Full Text] [Related]
5. Sodium cholate, a solubilizing agent for the necrosis avid radioiodinated hypericin in rabbits with acute myocardial infarction.
Cona MM; Feng Y; Zhang J; Li Y; Verbruggen A; Oyen R; Ni Y
Drug Deliv; 2015 May; 22(3):427-35. PubMed ID: 24417698
[TBL] [Abstract][Full Text] [Related]
6. Biodistribution and radiation dosimetry of radioiodinated hypericin as a cancer therapeutic.
Cona MM; Koole M; Feng Y; Liu Y; Verbruggen A; Oyen R; Ni Y
Int J Oncol; 2014 Mar; 44(3):819-29. PubMed ID: 24366374
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive detection and quantification of acute myocardial infarction in rabbits using mono-[123I]iodohypericin microSPECT.
Fonge H; Vunckx K; Wang H; Feng Y; Mortelmans L; Nuyts J; Bormans G; Verbruggen A; Ni Y
Eur Heart J; 2008 Jan; 29(2):260-9. PubMed ID: 18156139
[TBL] [Abstract][Full Text] [Related]
8. Radiopharmaceutical evaluation of (131)I-protohypericin as a necrosis avid compound.
Liu X; Feng Y; Jiang C; Lou B; Li Y; Liu W; Yao N; Gao M; Ji Y; Wang Q; Huang D; Yin Z; Sun Z; Ni Y; Zhang J
J Drug Target; 2015 Jun; 23(5):417-26. PubMed ID: 25655506
[TBL] [Abstract][Full Text] [Related]
9. Biodistribution and anti-tumor efficacy of intratumorally injected necrosis-avid theranostic agent radioiodinated hypericin in rodent tumor models.
Liu W; Zhang D; Feng Y; Li Y; Huang D; Jiang C; Gao M; Peng F; Wang X; Jing S; Jiang X; Ni Y; Zhang J
J Drug Target; 2015 May; 23(4):371-9. PubMed ID: 25572455
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of tumor affinity of mono-[(123)I]iodohypericin and mono-[(123)I]iodoprotohypericin in a mouse model with a RIF-1 tumor.
Fonge H; Van de Putte M; Huyghe D; Bormans G; Ni Y; de Witte P; Verbruggen A
Contrast Media Mol Imaging; 2007; 2(3):113-9. PubMed ID: 17546702
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Necrosis Avidity and Potential for Rapid Imaging of Necrotic Myocardium of Radioiodinated Hypocrellins.
Jin Q; Zhao J; Gao M; Feng Y; Liu W; Yin Z; Li T; Song S; Ni Y; Zhang J; Huang D; Zhang D
Mol Imaging Biol; 2018 Aug; 20(4):551-561. PubMed ID: 29305726
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of hypericin: effect of aggregation on targeting biodistribution.
Liu X; Jiang C; Li Y; Liu W; Yao N; Gao M; Ji Y; Huang D; Yin Z; Sun Z; Ni Y; Zhang J
J Pharm Sci; 2015 Jan; 104(1):215-22. PubMed ID: 25395358
[TBL] [Abstract][Full Text] [Related]
13. Hypericin as a marker for determination of tissue viability after intratumoral ethanol injection in a murine liver tumor model.
Van de Putte M; Wang H; Chen F; de Witte PA; Ni Y
Acad Radiol; 2008 Jan; 15(1):107-13. PubMed ID: 18078913
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of a 68Ga labeled pamoic acid derivative for in vivo visualization of necrosis using positron emission tomography.
Prinsen K; Li J; Vanbilloen H; Vermaelen P; Devos E; Mortelmans L; Bormans G; Ni Y; Verbruggen A
Bioorg Med Chem; 2010 Jul; 18(14):5274-81. PubMed ID: 20580560
[TBL] [Abstract][Full Text] [Related]
15. Pretargeting of necrotic tumors with biotinylated hypericin using 123I-labeled avidin: evaluation of a two-step strategy.
Marysael T; Bauwens M; Ni Y; Bormans G; Rozenski J; de Witte P
Invest New Drugs; 2012 Dec; 30(6):2132-40. PubMed ID: 22187204
[TBL] [Abstract][Full Text] [Related]
16. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis.
Fonge H; Chitneni SK; Lixin J; Vunckx K; Prinsen K; Nuyts J; Mortelmans L; Bormans G; Ni Y; Verbruggen A
Bioconjug Chem; 2007; 18(6):1924-34. PubMed ID: 17929883
[TBL] [Abstract][Full Text] [Related]
17. Radioiodinated hypericin disulfonic acid sodium salts as a DNA-binding probe for early imaging of necrotic myocardium.
Duan X; Yin Z; Jiang C; Jin Q; Zhang D; Sun Z; Ye W; Zhang J
Eur J Pharm Biopharm; 2017 Aug; 117():151-159. PubMed ID: 28414189
[TBL] [Abstract][Full Text] [Related]
18. Discovery of Radioiodinated Monomeric Anthraquinones as a Novel Class of Necrosis Avid Agents for Early Imaging of Necrotic Myocardium.
Wang Q; Yang S; Jiang C; Li J; Wang C; Chen L; Jin Q; Song S; Feng Y; Ni Y; Zhang J; Yin Z
Sci Rep; 2016 Feb; 6():21341. PubMed ID: 26878909
[TBL] [Abstract][Full Text] [Related]
19. A dual-targeting anticancer approach: soil and seed principle.
Li J; Sun Z; Zhang J; Shao H; Cona MM; Wang H; Marysael T; Chen F; Prinsen K; Zhou L; Huang D; Nuyts J; Yu J; Meng B; Bormans G; Fang Z; de Witte P; Li Y; Verbruggen A; Wang X; Mortelmans L; Xu K; Marchal G; Ni Y
Radiology; 2011 Sep; 260(3):799-807. PubMed ID: 21712473
[TBL] [Abstract][Full Text] [Related]
20. Effects of skeleton structure on necrosis targeting and clearance properties of radioiodinated dianthrones.
Zhang D; Jiang C; Yang S; Gao M; Huang D; Wang X; Shao H; Feng Y; Sun Z; Ni Y; Zhang J; Yin Z
J Drug Target; 2016; 24(6):566-77. PubMed ID: 26586010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
